-
2
-
-
26944442801
-
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease
-
DOI 10.1681/ASN.2004070597
-
Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ (2005) Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 16:1803-1810. (Pubitemid 41716487)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.6
, pp. 1803-1810
-
-
Weiner, D.E.1
Tighiouart, H.2
Vlagopoulos, P.T.3
Griffith, J.L.4
Salem, D.N.5
Levey, A.S.6
Sarnak, M.J.7
-
3
-
-
0141954949
-
Morbidity and mortality in children with anemia at initiation of dialysis
-
DOI 10.1007/s00467-003-1214-1
-
Warady B, Ho M (2003) Morbidity and mortality in children with anemia at initiation of dialysis. Pediatr Nephrol 18:1055-1062. (Pubitemid 37236222)
-
(2003)
Pediatric Nephrology
, vol.18
, Issue.10
, pp. 1055-1062
-
-
Warady, B.A.1
Ho, M.2
-
4
-
-
0023120533
-
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin
-
Eschbach JW, Egrie JC, Downing MR, Browne JK, Admson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73-78.
-
(1987)
N Engl J Med
, vol.316
, pp. 73-78
-
-
Eschbach, J.W.1
Egrie, J.C.2
Downing, M.R.3
Browne, J.K.4
Admson, J.W.5
-
5
-
-
33750522840
-
Clinical practice guidelines for anemia in chronic kidney diseases
-
National Kidney Foundation, KDOKI
-
National Kidney Foundation, KDOKI (2006) Clinical practice guidelines for anemia in chronic kidney diseases. Am J Kidney Dis 47:s1-s14.
-
(2006)
Am J Kidney Dis
, vol.47
-
-
-
8
-
-
0141786792
-
Hemoglobin variability in epoetin-treated hemodialysis patients
-
DOI 10.1046/j.1523-1755.2003.00229.x
-
Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, Deoreo PB (2003) Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int 64:1514-1521. (Pubitemid 37153820)
-
(2003)
Kidney International
, vol.64
, Issue.4
, pp. 1514-1521
-
-
Berns, J.S.1
Elzein, H.2
Lynn, R.I.3
Fishbane, S.4
Meisels, I.S.5
Deoreo, P.B.6
-
9
-
-
0037228098
-
Effect of variability in anemia management on hemoglobin outcomes in ESRD
-
DOI 10.1053/ajkd.2003.50030
-
Lacson E Jr, Ofsthun N, Lazarus JM (2003) Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 41:111-124. (Pubitemid 36043358)
-
(2003)
American Journal of Kidney Diseases
, vol.41
, Issue.1
, pp. 111-124
-
-
Lacson Jr., E.1
Ofsthun, N.2
Lazarus, J.M.3
-
10
-
-
32644457068
-
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
-
DOI 10.1111/j.1523-1755.2005.00532.x, PII 4494716
-
Fishbane S, Berns JS (2005) Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68:1337-1343. (Pubitemid 43246455)
-
(2005)
Kidney International
, vol.68
, Issue.3
, pp. 1337-1343
-
-
Fishbane, S.1
Berns, J.S.2
-
11
-
-
38749142226
-
Hemoglobin level variability: Associations with mortality
-
Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ (2008) Hemoglobin level variability: associations with mortality. Clin J Am Soc Nephrol 3:133-138.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 133-138
-
-
Gilbertson, D.T.1
Ebben, J.P.2
Foley, R.N.3
Weinhandl, E.D.4
Bradbury, B.D.5
Collins, A.J.6
-
12
-
-
0032737391
-
Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients
-
Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J, Egrie J (1999) Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. J Am Soc Nephrol 10:2392-2395. (Pubitemid 29501473)
-
(1999)
Journal of the American Society of Nephrology
, vol.10
, Issue.11
, pp. 2392-2395
-
-
Macdougall, I.C.1
Gray, S.J.2
Elston, O.3
Breen, C.4
Jenkins, B.5
Browne, J.6
Egrie, J.7
-
13
-
-
0037317083
-
Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo)
-
DOI 10.1093/ndt/18.2.362
-
Locatelli F, Canaud B, Giacardy F, Martin-Malo A, Baker N, Wilson J (2003) Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo). Nephrol Dial Transplant 18:362-369. (Pubitemid 36181689)
-
(2003)
Nephrology Dialysis Transplantation
, vol.18
, Issue.2
, pp. 362-369
-
-
Locatelli, F.1
Canaud, B.2
Giacardy, F.3
Martin-Malo, A.4
Baker, N.5
Wilson, J.6
-
14
-
-
2442702016
-
Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients
-
DOI 10.1093/ndt/gfh106
-
Brunkhorst R, Bommer J, Braun J, Haag-Weber M, Gill C, Wagner J, Wagener T, German Aranesp Study Group (2004) Darbepoetin alfa effectively maintains hemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. Nephrol Dial Transplant 19:1224-1230. (Pubitemid 38655907)
-
(2004)
Nephrology Dialysis Transplantation
, vol.19
, Issue.5
, pp. 1224-1230
-
-
Brunkhorst, R.1
Bommer, J.2
Braun, J.3
Haag-Weber, M.4
Gill, C.5
Wagner, J.6
Wagener, T.7
-
15
-
-
0036280663
-
Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients
-
DOI 10.1053/ajkd.2002.33919
-
Nissenson AR, Swan SK, Lindberg JS, Soroka SD, Beatey R, Wang C, Picarello N, McDermott-Vitak A, Maroni BJ (2002) Randomized, controlled trial of darbepoetin alfa for the treatment of anemia in hemodialysis patients. Am J Kidney Dis 40:110-118. (Pubitemid 34701218)
-
(2002)
American Journal of Kidney Diseases
, vol.40
, Issue.1
, pp. 110-118
-
-
Nissenson, A.R.1
Swan, S.K.2
Lindberg, J.S.3
Soroka, S.D.4
Beatey, R.5
Wang, C.6
Picarello, N.7
McDermott-Vitak, A.8
Maroni, B.J.9
-
16
-
-
1542330029
-
Clinical experience with darbepoietin alfa (NESP) in children undergoing hemodialysis
-
DOI 10.1007/s00467-003-1364-1
-
De Palo T, Giordano M, Palumbo F, Bellantuono R, Messina G, Colella V, Caringella AD (2004) Clinical experience with darbepoetin alfa (NESP) in children undergoing hemodialysis. Pediatr Nephrol 19:337-340. (Pubitemid 38313021)
-
(2004)
Pediatric Nephrology
, vol.19
, Issue.3
, pp. 337-340
-
-
De Palo, T.1
Giordano, M.2
Palumbo, F.3
Bellantuono, R.4
Messina, G.5
Collela, V.6
Caringella, A.D.7
-
17
-
-
31644439003
-
Darbepoetin alfa (Aranesp) in children with chronic renal failure
-
DOI 10.1111/j.1523-1755.2005.00592.x, PII 4494778
-
Geary DF, Keating LE, Vigneux A, Stephens D, Hébert D, Harvey EA (2005) Darbepoetin alfa (Aranesp) in children with chronic renal failure. Kidney Int 68:1759-1765. (Pubitemid 43169920)
-
(2005)
Kidney International
, vol.68
, Issue.4
, pp. 1759-1765
-
-
Geary, D.F.1
Keating, L.E.2
Vigneux, A.3
Stephens, D.4
Hebert, D.5
Harvey, E.A.6
-
18
-
-
43749117511
-
Methoxy polyethylene glycol-epoetin beta: A review of its use in the management of anaemia associated with chronic kidney disease
-
DOI 10.2165/00003495-200868080-00009
-
Curran MP, McCormack P (2008) Methoxy polyethylen glycolepoetin beta. A review of its use in the management of anaemia associated with chronic kidney disease. Drugs 68:1139-1156. (Pubitemid 351693680)
-
(2008)
Drugs
, vol.68
, Issue.8
, pp. 1139-1156
-
-
Curran, M.P.1
McCormack, P.L.2
-
19
-
-
36249017329
-
Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: A randomized trial
-
DOI 10.1053/j.ajkd.2007.08.013, PII S0272638607011973
-
Klinger M, Arias M, Vargemezis V, Besarab A, Sulowicz W, Gernthotlz T, Ciechanowski K, Dougherty FC, Beyer U (2007) Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. Am J Kidney Dis 50:989-1000. (Pubitemid 350122810)
-
(2007)
American Journal of Kidney Diseases
, vol.50
, Issue.6
, pp. 989-1000
-
-
Klinger, M.1
Arias, M.2
Vargemezis, V.3
Besarab, A.4
Sulowicz, W.5
Gerntholtz, T.6
Ciechanowski, K.7
Dougherty, F.C.8
Beyer, U.9
-
20
-
-
38349014009
-
C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks
-
RUBRA Study Investigators
-
Spinowitz B, Coyne D, Lok Ch, Fraticelli M, Azer M, Dalal S, Villa G, Rosansky S, Adamis H, Beyer U, RUBRA Study Investigators (2008) C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks. Am J Nephrol 28:280-289.
-
(2008)
Am J Nephrol
, vol.28
, pp. 280-289
-
-
Spinowitz, B.1
Coyne, D.2
Lok, C.3
Fraticelli, M.4
Azer, M.5
Dalal, S.6
Villa, G.7
Rosansky, S.8
Adamis, H.9
Beyer, U.10
-
21
-
-
24044499617
-
Sodium ferric gluconate complex therapy in anemic children on hemodialysis
-
DOI 10.1007/s00467-005-1904-y
-
Warady BA, Zobrist RH, Wu J, Finan E (2005) Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol 20:1320-1327. (Pubitemid 41222981)
-
(2005)
Pediatric Nephrology
, vol.20
, Issue.9
, pp. 1320-1327
-
-
Warady, B.A.1
Zobrist, R.H.2
Wu, J.3
Finan, E.4
Arnone, W.5
Peco-Antic, A.6
Nadine, M.B.7
Benfield, M.R.8
Diatchenko, I.V.9
Jarmolinski, T.10
Kuanshkaliev, R.K.11
Kudinov, V.I.12
Lerner, G.R.13
Marczak, E.14
Nazarov, G.K.15
Nowicki, M.16
Shakirov, I.D.17
Stankiewicz, R.18
Szprynger, K.19
Chew-Wong, A.20
Yorgin, P.D.21
Zajaczkowska, M.M.22
Zverev, D.V.23
Zoch-Zwierz, W.24
Zwolinska, D.25
more..
-
22
-
-
10744233706
-
The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee
-
DOI 10.1007/s00467-003-1126-0
-
Schröder C, the European Pediatric Peritoneal Dialysis Working Group (2003) The management of anemia in pediatric peritoneal dialysis patients. Guidelines by an ad hoc European committee. Pediatr Nephrol 18:805-809. (Pubitemid 36949968)
-
(2003)
Pediatric Nephrology
, vol.18
, Issue.8
, pp. 805-809
-
-
Schroder, C.H.1
Edefonti, A.2
Fischbach, M.3
Klaus, G.4
Ronnholm, K.5
Schaefer, F.6
Simkova, E.7
Stefanidis, D.8
Strazdins, V.9
Vande Walle, J.10
Watson, A.11
Zurowska, A.12
-
23
-
-
34548207889
-
Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly
-
Sulowicz W, Locatelli F, Ryckelynck J, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U (2007) Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Clin J Am Soc Nephrol 2:637-646.
-
(2007)
Clin J Am Soc Nephrol
, vol.2
, pp. 637-646
-
-
Sulowicz, W.1
Locatelli, F.2
Ryckelynck, J.3
Balla, J.4
Csiky, B.5
Harris, K.6
Ehrhard, P.7
Beyer, U.8
-
24
-
-
77956258983
-
Maintenance treatment of renal anaemia in hemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: A randomized comparative trial
-
PATRONUS Investigators
-
Carrera F, Lok Ch, de Francisco A, Locatelli F, Mann J, Canaud B, Kerr PG, Macdougall IC, Besarab A, Villa G, Kazes I, Van Vlem B, Jolly S, Beyer U, Dougherty FC, PATRONUS Investigators (2010) Maintenance treatment of renal anaemia in hemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trial. Nephrol Dial Transplant 25:4009-4017.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 4009-4017
-
-
Carrera, F.1
Lok, C.2
De Francisco, A.3
Locatelli, F.4
Mann, J.5
Canaud, B.6
Kerr, P.G.7
Macdougall, I.C.8
Besarab, A.9
Villa, G.10
Kazes, I.11
Van Vlem, B.12
Jolly, S.13
Beyer, U.14
Dougherty, F.C.15
-
25
-
-
42549141095
-
C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: Results of a randomized clinical trial
-
ARCTOS Study Investigators
-
Macdougall IC, Walker R, Provenzano R, de Alvaro F, Locay HR, Nader PC, Locatelli F, Dougherty FC, Beyer U, ARCTOS Study Investigators (2008) C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. Clin J Am Soc Nephrol 3:337-347.
-
(2008)
Clin J Am Soc Nephrol
, vol.3
, pp. 337-347
-
-
Macdougall, I.C.1
Walker, R.2
Provenzano, R.3
De Alvaro, F.4
Locay, H.R.5
Nader, P.C.6
Locatelli, F.7
Dougherty, F.C.8
Beyer, U.9
-
26
-
-
33750983605
-
Correction of anemia with epoetin alfa in chronic kidney disease
-
DOI 10.1056/NEJMoa065485
-
Singh A, Szczech L, Tang K, Barnhart H, Sapp S, Wolfson M, Reddan B, for the CHOIR Investigators (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085-2098. (Pubitemid 44749317)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.20
, pp. 2085-2098
-
-
Singh, A.K.1
Szczech, L.2
Tang, K.L.3
Barnhart, H.4
Sapp, S.5
Wolfson, M.6
Reddan, D.7
-
27
-
-
33751002326
-
Normalization of hemoglobin level in patients with chronic kidney disease and anemia
-
DOI 10.1056/NEJMoa062276
-
Drüeke T, Locatelli F, Clyne N, Eckardt K, Macdougall I, Tsakiris D, Burger H, Scherhag A, for the CREATE Investigators (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355:2071-2084. (Pubitemid 44749316)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.20
, pp. 2071-2084
-
-
Drueke, T.B.1
Locatelli, F.2
Clyne, N.3
Eckardt, K.-U.4
Macdougall, I.C.5
Tsakiris, D.6
Burger, H.-U.7
Scherhag, A.8
-
28
-
-
33750014056
-
-
Accessed 20 January 2011
-
Scientific Discussion http://www.emea.europa.eu/docs/en-GB/document- library/EPAR-Scientific-Discussion/human/000739/WC500033669.pdf. Accessed 20 January 2011.
-
Scientific Discussion
-
-
|